Ocrevus

Active Molecule: ocrelizumab 300 mgGeneric Formulations →

Branded and Generic MedicinesSuper speciality Medicines

Select Quantity

Pack

Description

Ocrevus (ocrelizumab) is a prescription medication used to treat adult patients with relapsing and primary progressive forms of Multiple Sclerosis (MS).

Product Information

Form

Injection

Strength

300 mg

Pack Size

1 Vial of 10 ml

Storage

Store at 2°C to 8°C

Manufactured By

Roche Diagnostics GmbH

Marketed By / TM Owner

F. Hoffmann-La Roche Ltd

Institutional Quality & Supply Assurance

Meeting Global Pharmaceutical Standards for Trusted International Trade

✓ Audited Supply Chain

Authorised Sourcing

Procured through authorised distributors and companies, ensuring reliable quality and supply chain traceability.

Cold-Chain Monitored

Active temperature logging during air cargo export, maintaining Refrigerated (2°C–8°C) and CRT (15°C–25°C) conditions as per international shipping standards.

QA Verified

Pre-dispatch inspection, tamper-evident packing, and documentation verification for every shipment.

Uses

Treatment of Multiple Sclerosis

Disclaimer

At ExSell Laboratories Pvt. Ltd., we aim to provide information that is accurate and reliable. All content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While every effort is made to maintain accuracy, the information provided may contain errors or omissions, or may not reflect the latest developments. Please consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks, and registered trademarks displayed on this website are the property of their respective owners. ExSell Laboratories Pvt. Ltd. and this website are not affiliated with, endorsed by, or authorized by any such trademark owners, unless expressly stated. References to product names or trademarks are made solely for descriptive and informational purposes, and no commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Nothing herein constitutes promotion, advertising, or an offer for sale of any medicinal product.

All trademarks and brand names on this website are used strictly in accordance with the Trade Marks Act, 1999 — specifically Sections 30 and 30(1) governing fair use — and any related parallel trade is conducted consistent with the trademark exhaustion and fair-use provisions of the Act, as well as India's obligations as a WTO member under the TRIPS Agreement.

"Trademark ownership is duly attributed under the 'Marketing/TM Owner' section in accordance with applicable statutory requirements."

Medical & Supply FAQs

Frequently Asked Questions about Ocrevus

Essential information on active composition, quality standards, cold-chain storage, and international export.

What is Ocrevus and what active ingredient does it contain?

Ocrevus is a certified pharmaceutical product from our Global export catalogue formulated as an Injection (300 mg). It contains the active pharmaceutical ingredient ocrelizumab 300 mg, manufactured by Roche Diagnostics GmbH.

Who manufactures Ocrevus and is it quality certified?

Ocrevus is manufactured by Roche Diagnostics GmbH – Meeting Global Pharmaceutical Standards for Trusted International Trade. ExSell Laboratories delivers authenticated batches sourced through verified, compliant supply channels, backed by complete regulatory documentation.

How should Ocrevus be stored to maintain potency?

Ocrevus must be stored according to manufacturer instructions: Store at 2°C to 8°C. ExSell Laboratories maintains active temperature logging during air cargo export, maintaining Refrigerated (2°C–8°C) and CRT (15°C–25°C) conditions as per international shipping standards.

Can Ocrevus be ordered in bulk for international export?

Yes, ExSell Laboratories is a licensed global pharmaceutical exporter supplying hospitals, pharmacies, government procurement agencies, and distributors in 45+ countries. Contact our sales team for bulk quotation, MOQ, and international shipping options.

Generic Substitutes

Substitutes & Brands with ocrelizumab 300 mg

Verified equivalent brands and bioequivalent formulations containing ocrelizumab 300 mg.

Clinical Notice:These brands contain the same active molecule (ocrelizumab 300 mg). Dosage forms and strengths may vary. Always consult your prescribing physician before switching brands.